drugset / Trial / NCT00691834

Safety and Efficacy on Cell-based Therapy in Patients With Recent Large Acute Myocardial Infarction

NCT00691834 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to test bone marrow mononuclear cells for patients with recent heart attack who are at high risk of experiencing heart failure. This study drug is made of you own cells. Studies similar to this one have suggested that the use of cell-based transfer after heart attack can improve the recuperation of the heart. The purpose of this study is to assess whether cell transfer can improve the healing of the heart after a heart attack.

Timeline

Start
2009-08
Primary completion
2009-08
Completion
2009-08

Outcome

Outcome not reported

Stopped: “Study never received IRB approval. Study was never pursued.”

Drugs

EvaluationDrugModalityDoseRoute
Subject unfractionated bone marrow mononuclear cells Unknown 5e+08 cells Other